FR-31564, a new phosphonic acid antibiotic: bacterial resistance and membrane permeability
- PMID: 7378171
- DOI: 10.7164/antibiotics.33.44
FR-31564, a new phosphonic acid antibiotic: bacterial resistance and membrane permeability
Abstract
Mutants which acquired resistance to FR-31564 were also resistant to fosfomycin and vice versa. Some exceptions to cross-resistance were found among clinical isolates of certain species. FR-31564 was found to be incorporated into bacterial cells more efficiently than fosfomycin although the extent of incorporation varied among species. In particular, the uptake rate of FR-31564 by a strain of Pseudomonas aeruginosa was ten times that of fosfomycin. The uptake rate of FR-31564 by both FR-31564- and fosfomycin-resistant mutants was less than one-tenth of that by the parent strain. FR-31564 was scarcely inactivated in the culture broths of FR-31564-resistant strains. All of the FR-31564-resistant mutants of P. aeruginosa came under the classification of strains lacking an L-alpha-glycerophosphate transport system.
Similar articles
-
Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.Antimicrob Agents Chemother. 1982 Oct;22(4):560-3. doi: 10.1128/AAC.22.4.560. Antimicrob Agents Chemother. 1982. PMID: 7181471 Free PMC article.
-
In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.J Antibiot (Tokyo). 1980 Jan;33(1):36-43. doi: 10.7164/antibiotics.33.36. J Antibiot (Tokyo). 1980. PMID: 7372548
-
Antibacterial activity of fosmidomycin on chromosomic and plasmid-determined fosfomycin-resistant strains.Chemioterapia. 1985 Apr;4(2):170-5. Chemioterapia. 1985. PMID: 4006006
-
Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences.Int J Antimicrob Agents. 2019 Jan;53(1):22-28. doi: 10.1016/j.ijantimicag.2018.09.013. Epub 2018 Sep 27. Int J Antimicrob Agents. 2019. PMID: 30268576 Review.
-
[Antibiotics of the phosphonic acid group].Antibiot Med Biotekhnol. 1987 Jan;32(1):66-75. Antibiot Med Biotekhnol. 1987. PMID: 3551820 Review. Russian. No abstract available.
Cited by
-
A computational study of the molecular basis of antibiotic resistance in a DXR mutant.J Comput Aided Mol Des. 2019 Oct;33(10):927-940. doi: 10.1007/s10822-019-00229-5. Epub 2019 Oct 26. J Comput Aided Mol Des. 2019. PMID: 31654265
-
Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.Antimicrob Agents Chemother. 1982 Oct;22(4):560-3. doi: 10.1128/AAC.22.4.560. Antimicrob Agents Chemother. 1982. PMID: 7181471 Free PMC article.
-
Activity of fosmidomycin in an in vitro model of the treatment of bacterial cystitis.Infection. 1987 Nov-Dec;15(6):465-8. doi: 10.1007/BF01647239. Infection. 1987. PMID: 3325431
-
In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.Antimicrob Agents Chemother. 1981 Jun;19(6):1013-23. doi: 10.1128/AAC.19.6.1013. Antimicrob Agents Chemother. 1981. PMID: 7271270 Free PMC article.
-
Development and application of an LC-MS/MS method for quantification of fosmidomycin in human and rat plasma.Malar J. 2025 Jul 25;24(1):243. doi: 10.1186/s12936-025-05489-1. Malar J. 2025. PMID: 40713723 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical